|Bid||0.0665 x N/A|
|Ask||0.0815 x N/A|
|Day's Range||0.0735 - 0.0735|
|52 Week Range||0.0455 - 0.1090|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 29, 2023 - Apr 03, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress to achieve regulatory approval in Canada for its Reveal® TP (Syphilis) antibody test.
PROVIDENCE, R.I. & HALIFAX, Nova Scotia, February 20, 2023--Maternova gains distribution rights across the U.S. and Latin America for MedMira’s rapid diagnostics for sexually transmitted diseases.
Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the singing of a multinational distribution agreement with Maternova, Inc., Rhode Island, USA.